Abstract
Purpose: to predict the occurrence of late subcutaneous radiation induced fibrosis (RIF) after partial breast irradiation (PBI) for breast carcinoma by using machine learning (ML) models and radiomic features from 3D Biologically Effective Dose (3D-BED) and Relative Electron Density (3D-RED).Methods: 165 patients underwent external PBI following a hypo-fractionation protocol consisting of 40 Gy/10 fractions, 35 Gy/7 fractions, and 28 Gy/4 fractions, for 73, 60, and 32 patients, respectively. Physicians evaluated toxicity at regular intervals by the Common Terminology Adverse Events (CTAE) version 4.0. RIF was assessed every 3 months after the completion of radiation course and scored prospectively. RIF was experienced by 41 (24.8%) patients after average 5 years of follow up.The Hounsfield Units (HU) of the CT-images were converted into relative electron density (3D-RED) and Dose maps into Biologically Effective Dose (3D-BED), respectively. Shape, first-order and textural features of 3D-RED and 3D-BED were calculated in the planning target volume (PTV) and breast. Clinical and demographic variables were also considered (954 features in total). Imbalance of the dataset was addressed by data augmentation using ADASYN technique. A subset of non-redundant features that best predict the data was identified by sequential feature selection. Support Vector Machines (SVM), ensemble machine learning (EML) using various aggregation algorithms and Naive Bayes (NB) classifiers were trained on patient dataset to predict RIF occurrence. Models were assessed using sensitivity and specificity of the ML classifiers and the area under the receiver operator characteristic curve (AUC) of the score functions in repeated 5-fold cross validation on the augmented dataset.Results: The SVM model with seven features was preferred for RIF prediction and scored sensitivity 0.83 (95% CI 0.80–0.86), specificity 0.75 (95% CI 0.71–0.77) and AUC of the score function 0.86 (0.85–0.88) on cross-validation. The selected features included cluster shade and Run Length Non-uniformity of breast 3D-BED, kurtosis and cluster shade from PTV 3D-RED, and 10th percentile of PTV 3D-BED.Conclusion: Textures extracted from 3D-BED and 3D-RED in the breast and PTV can predict late RIF and may help better select patient candidates to exclusive PBI.
Highlights
Subcutaneous radiation induced fibrosis (RIF) is characterized by a progressive induration and thickening of the subcutaneous tissues and is one of the late adverse effects of breast radiotherapy (RT) mostly affecting cosmesis
Models to predict Normal Tissue Complication Probability (NTCP) for RIF after breast RT have been first fitted to published data of rates of incidence from whole breast irradiation (WBI) [2]
Models for NTCP of RIF have been refined by including dose volume data from simulated dose distributions of WBI [3] and partial breast irradiations (PBI) [4]
Summary
Subcutaneous radiation induced fibrosis (RIF) is characterized by a progressive induration and thickening of the subcutaneous tissues and is one of the late adverse effects of breast radiotherapy (RT) mostly affecting cosmesis. It is a dose dependent and slowly progressive side effect originating from a proliferative response of surviving fibrocytes to growth factors (e.g., the transforming growth factor β (TGF-β), released in response to tissue injury) [1]. Models to predict Normal Tissue Complication Probability (NTCP) for RIF after breast RT have been first fitted to published data of rates of incidence from whole breast irradiation (WBI) [2]. The combination of quantitative analysis of radiological images with Machine Learning (ML) methods, known as “radiomics,” has been applied to predict side effects of RT such as lung-injury following Stereotactic Body RT (SBRT) for lung cancer [6], gastrointestinal and genitourinary toxicities [7] and xerostomia [8]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.